150 related articles for article (PubMed ID: 4976851)
21. [Hyperfibrinolysis].
Marx R; Matis P
Hoppe Seylers Z Physiol Chem; 1968 Jul; 349(7):934-5. PubMed ID: 5303675
[No Abstract] [Full Text] [Related]
22. Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.
Ambrus JL; Schimert G; Lajos TZ; Ambrus CM; Mink IB; Lassman HB; Moore RH; Melzer J
J Med; 1971; 2(2):65-81. PubMed ID: 4329735
[No Abstract] [Full Text] [Related]
23. [Antifibrinolytic agents and their therapeutic use].
Fischer M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):64-77. PubMed ID: 4189375
[No Abstract] [Full Text] [Related]
24. On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors.
Ambrus CM; Ambrus JL; Lassman HB; Mink IB
Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):67-85. PubMed ID: 4257701
[No Abstract] [Full Text] [Related]
25. Comparative studies of fibrinolytic inhibitors in vitro.
Maki M; Beller FK
Thromb Diath Haemorrh; 1966 Dec; 16(3):668-86. PubMed ID: 4231539
[No Abstract] [Full Text] [Related]
26. [Fibrinolytic bleedings in urology].
Lipsky H; Hubmer O
Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209
[No Abstract] [Full Text] [Related]
27. [Antifibrinolytic agents, a new class of drugs].
Markwardt F
Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
[No Abstract] [Full Text] [Related]
28. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
Thorsen S; Astrup T
Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
[No Abstract] [Full Text] [Related]
29. [Comparative study of the effect of fibrinolysin inhibitors on the degranulation grade of basophilic granulocytes].
Frick G; Frick U
Z Gesamte Inn Med; 1968 Jun; 23(11):321-5. PubMed ID: 5304218
[No Abstract] [Full Text] [Related]
30. [Animal experimental studies of the effect of synthetic antifibrinolytics].
Markwardt F; Klöcking HP
Acta Biol Med Ger; 1966; 17(6):746-54. PubMed ID: 5990894
[No Abstract] [Full Text] [Related]
31. Studies on the fibrinolytic activity in human semen studied by gel filtration.
Hisazumi H
Invest Urol; 1970 Mar; 7(5):410-21. PubMed ID: 5461871
[No Abstract] [Full Text] [Related]
32. [On the combined effect of PAMBA and contrykal].
Richter M; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):90-2. PubMed ID: 4189379
[No Abstract] [Full Text] [Related]
33. Anti-inflammatory effect of antiplasmin agents, -aminocaproic acid and trans-4-aminomethyl-cyclohexane carboxylic acid, in rats.
Yamasaki H; Tsuji H; Kitamura M
Acta Med Okayama (1952); 1970 Oct; 24(5):509-25. PubMed ID: 4256470
[No Abstract] [Full Text] [Related]
34. [Studies on antiphlogistic effects of fibrinolysin inhibitors].
Feyen H; Nissen H; Rasche H; Hiemeyer V
Z Rheumaforsch; 1970; 29(9):276-86. PubMed ID: 4394179
[No Abstract] [Full Text] [Related]
35. [Ultra-micro-determination of plasmin using a fibrin plate. 3. Relationship to antiplasmin agents].
Miyatani K; Fukui I
Rinsho Byori; 1971 Dec; 19(12):859-62. PubMed ID: 4258880
[No Abstract] [Full Text] [Related]
36. [On the influence of eta-aminocaproic acid, PAMBA and PAMBA derivatives on the antigen-antibody reaction in vitro].
Stein P; Bannath G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):221-4. PubMed ID: 4174662
[No Abstract] [Full Text] [Related]
37. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
Geratz JD
Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
[No Abstract] [Full Text] [Related]
38. [The effect of antifibrinolytic agents on thrombocyte aggregation in vitro and in vivo].
Hladovec J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):524-8. PubMed ID: 4193170
[No Abstract] [Full Text] [Related]
39. Comparative studies on inhibitors of fibrinolysis in vitro and in vivo.
Deutsch E; Fischer M
Acta Haematol; 1968; 39(1):1-12. PubMed ID: 4968865
[No Abstract] [Full Text] [Related]
40. [Determination of tissue penetrability and therapeutic dose of epsilon-aminocaproic acid, AMCHA and trasylol with the help of direct homogenate- plasma-thromboelastography examplified on the fibrinolytically active myometrium].
Schmidt-Matthiesen H; Schreinert B
Klin Wochenschr; 1968 Jul; 46(13):730-1. PubMed ID: 5306518
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
